Compounds > 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Page last updated: 2024-09-03

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and B-Cell Chronic Lymphocytic Leukemia

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jamieson, GP; Snook, MB; Thurlow, PJ; Wiley, JS1
Cornish, JE; Gargett, CE; Wiley, JS1
Bendall, LJ; Gu, B; Wiley, JS1
Gargett, CE; Jamieson, GP; Snook, MB; Wiley, JS; Zhang, W1
Bendall, LJ; Buell, GN; Chessell, IP; Gu, BJ; Wiley, JS; Zhang, WY1

Other Studies

5 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters.
    Journal of cellular physiology, 1996, Volume: 166, Issue:3

    Topics: Adenosine Triphosphate; Alkaloids; Calcium; Cells, Cultured; Down-Regulation; Humans; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Magnesium; Protein Kinase C; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1996
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    British journal of pharmacology, 1997, Volume: 122, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides

1997
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
    Blood, 1998, Aug-01, Volume: 92, Issue:3

    Topics: Adenosine Triphosphate; B-Lymphocytes; Biomarkers, Tumor; Calcium; Humans; Hydroxamic Acids; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloendopeptidases; Neoplasm Proteins; Neoplastic Stem Cells; Protease Inhibitors; Receptors, IgE; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Solubility; Tetradecanoylphorbol Acetate

1998
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
    The American journal of physiology, 1998, Volume: 275, Issue:5

    Topics: Adenosine Triphosphate; B-Lymphocytes; Barium; Calcium; Cell Membrane Permeability; Cells, Cultured; Cloning, Molecular; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Macrophages; Monocytes; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides

1998
Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
    American journal of physiology. Cell physiology, 2000, Volume: 279, Issue:4

    Topics: Adenosine Triphosphate; Antibodies, Monoclonal; Barium; Blood Platelets; Ethidium; Flow Cytometry; Humans; Intracellular Fluid; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Lymphocytes; Monocytes; Polymerase Chain Reaction; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reference Values; RNA, Messenger

2000